Morgan Stanley’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Morgan Stanley’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-13,706	Closed	-$11K	–	7079
2015 Q3	$11K	Buy	13,706 +296	+2%	+$329	﹤0.01%	6228
2015 Q2	$20K	Buy	13,410 +10,013	+295%	+$23.8K	﹤0.01%	6144
2015 Q1	$9K	Sell	3,397 -40	-1%	-$157	﹤0.01%	6252
2014 Q4	$15K	Buy	3,437 +1,127	+49%	+$5.93K	﹤0.01%	6131
2014 Q3	$16K	Sell	2,310 -3,187	-58%	-$31.5K	﹤0.01%	6088
2014 Q2	$81K	Buy	+5,497	New	+$95.4K	﹤0.01%	5592

Other funds holding RCPI

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return

IWMPD

Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.86% 1-Year Est. Return

Morgan Stanley's RCPI Position: Q4 2015 in Review

Morgan Stanley sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 13,706 shares — an estimated $11K sold.

Morgan Stanley first reported a position in RCPI in Q2 2014 and held it in 6 quarters. The position peaked at $81K in Q2 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

Morgan Stanley reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
Morgan Stanley sold 13,706 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $11K.
Morgan Stanley first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 6 quarters.
Morgan Stanley's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $81K in Q2 2014.
9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Morgan Stanley's 13F filing for Q4 2015, filed 9 Feb 2016.